Cationic lipids for nucleic acid delivery and preparation thereof
US-2025162978-A1 · May 22, 2025 · US
US11851391B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11851391-B2 |
| Application number | US-201916514276-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 17, 2019 |
| Priority date | Jul 17, 2018 |
| Publication date | Dec 26, 2023 |
| Grant date | Dec 26, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An antifungal composition and a method of treating a systemic fungal infection are provided herein. The antifungal composition includes a diaryl bishydrazone. The method includes administering a therapeutically effective amount of the diaryl bishydrazone to a subject in need thereof.
Opening claim text (preview).
What is claimed is: 1. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the aryl sulfoxides include S(═O)C 6 H 4 Z, with Z being selected from the group consisting of alkyl, alkoxy, and halogen. 2. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the aryl sulfones include S(═O) 2 C 6 H 4 Z, with Z being selected from the group consisting of alkyl, alkoxy, and halogen. 3. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the substituent of the first ring according to Formula I is in the 3 position. 4. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the substituent of the first ring according to Formula I is in the 4 position. 5. The composition of claim 4 , wherein the R in the substituent of the first ring is methyl. 6. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; wherein X is a substituted phenyl and the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof, wherein the substituted phenyl includes more than one substitution. 7. The composition of claim 6 , wherein the substituted phenyl is disubstituted. 8. The composition of claim 7 , wherein the disubstituted phenyl is halogen substituted.
Hydrazines · CPC title
Antimycotics · CPC title
Preparation of guanidine or its derivatives, i.e. compounds containing the group [IMAGE cpc-sch-C07C-0970.gif], the singly-bound nitrogen atoms not being part of nitro or nitroso groups · CPC title
having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings · CPC title
the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.